Investigating the Role of Genetic Polymorphism in the Exon 3 of ATG16L1 Gene in T2DM Patients: A Pilot Study
Main Article Content
Abstract
Objective Diabetes mellitus (DM) is a metabolic disease characterized by persistently high blood sugar levels and has several potential causes. We aimed to find out whether there are any single nucleotide polymorphisms in a particular region of the ATG16L1 gene which are linked to type 2 diabetes.
Methods A total of forty participants were included in this study; 20 were part of the patient group and had type 2 diabetes mellitus (T2DM), while 20 were part of the healthy control group. High-resolution melt (HRM) analysis was used for genotyping along with sequencing for confirmation of the results.
Results The melting behavior showed consistent DNA sequence in the exon 3 of the ATG16L1 gene in both the patient and the healthy control groups in the study.
Conclusions The ATG16L1 gene does not include any SNPs in the exon 3 region associated with type 2 diabetes. However, further studies are needed to determine the role of the autophagy gene in T2DM.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020; 21(17):6275. PubMed PMID: 32872570
Tian Y, Xu J, Huang T, Cui J, Zhang W, Song W, et al. A novel polymorphism (rs35612982) in CDKAL1 is a risk factor of type 2 diabetes: a case-control study. Kidney Blood Press Res. 2019;44:1313-26.
Ghodsi M, Keshtkar AA, Razi F, Mohammad Amoli M, Nasli-Esfahani E, Zarrabi F, et al. Association of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes. J Diabetes Metab Disord. 2021;20:1375-83.
Xiong Q, Li W, Li P, Yang M, Wu C, Eichinger L. The role of ATG16 in autophagy and the ubiquitin proteasome system. Cells. 2019;8:2. PubMed PMID: 30577509
Saitoh T, Fujita N, Jang MH, Uematsu S, Yang B-G, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1 production. Nature. 2008;456(7219):264-8.
Watada H, Fujitani Y. Minireview: Autophagy in pancreatic -cells and its implication in diabetes. Mol Endocrinol. 2015;29:338-48.
Liu H, Cao M-m, Wang Y, Li L-c, Zhu L-b, Xie G-y, et al. Endoplasmic reticulum stress is involved in the connection between inflammation and autophagy in type 2 diabetes. Gen Comp Endocrinol. 2015;210:124-9.
Sehrawat A, Mishra J, Mastana SS, Navik U, Bhatti GK, Reddy PH, et al. Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications. Biochim Biophys Acta Mol Basis Dis. 2023;1869(4):166666. PubMed PMID: 36791919
Gammoh N. The multifaceted functions of ATG16L1 in autophagy and related processes. J Cell Sci. 2020; 133(20):jcs249227. PubMed PMID: 33127840
Barlow AD, Thomas DC. Autophagy in diabetes: -Cell dysfunction, insulin resistance, and complications. DNA Cell Biol. 2015;34:252-60.
Marasco MR, Linnemann AK. -Cell autophagy in diabetes pathogenesis. Endocrinology. 2018;159:2127-41.
Alnaji HA, Omran R, Hasan AH, Al Nuwaini MQ. Diabetic retinopathy progression associated with haplotypes of two VEGFA SNPs rs2010963 and rs699947. Egyptian Journal of Basic and Applied Sciences. 2023; 10:123-34.
Alnaji HA, Alnaji HA, Hassan AH. Alterations of thyroid hormone levels and the risks of diabetic retinopathy in T2DM. Research Journal of Pharmacy and Technology. 2023;16:1053-9.
Alnaji HA, Hasan AH, Omran R, Al Nuwaini MQ. Association between the rs1800624 and rs80096349 SNPs and diabetic retinopathy: a pilot study. Ophthalmic Genet. 2025;46:40-6.
Gao X, Du Y, Lau WB, Li Y, Zhu S, Ma X-L. Atg16L1 as a novel biomarker and autophagy gene for diabetic retinopathy. J Diabetes Res. 2021; 2021:5398645. Pub Med PMID: 33791389
Masini M, Bugliani M, Lupi R, Del Guerra S, Boggi U, Filipponi F, et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia. 2009;52:1083-6.